{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:22:37Z","timestamp":1780755757707,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.nefro.2021.04.007","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T02:38:38Z","timestamp":1628822318000},"page":"506-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacological interventions for preventing complications in patients with idiopathic hypercalciuria: A systematic review"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2838-1525","authenticated-orcid":false,"given":"Natalia","family":"Ferre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1696-036X","authenticated-orcid":false,"given":"Ester","family":"Parada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Balaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5249-7907","authenticated-orcid":false,"given":"Albert","family":"Feliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Roqu\u00e9-Figuls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Victor A.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5041-459X","authenticated-orcid":false,"given":"Joaqu\u00edn","family":"Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2021.04.007_bib0280","first-page":"1077","article-title":"Idiopathic hypercalciuria: a preliminary report","volume":"46","author":"Albright","year":"1953","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.nefro.2021.04.007_bib0285","series-title":"Nefrolog\u00eda Pedi\u00e1trica 1","first-page":"475","article-title":"Idiopathic hypercalciuria [Hipercalciuria idiop\u00e1tica]","author":"Garc\u00eda-Nieto","year":"2000"},{"key":"10.1016\/j.nefro.2021.04.007_bib0290","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.ki.5002708","article-title":"24-h uric acid excretion and the risk of kidney stones","volume":"73","author":"Curhan","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2021.04.007_bib0295","first-page":"180","article-title":"Kidney calculi: pathophysiology and as a systemic disorder","volume":"11","author":"Shadman","year":"2017","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.nefro.2021.04.007_bib0300","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.nefro.2019.02.011","article-title":"The idiopathic hypercalciuria reviewed. Metabolic abnormality or disease?","volume":"39","author":"Garc\u00eda Nieto","year":"2019","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefro.2021.04.007_bib0305","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0002-9343(02)01152-X","article-title":"Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria","volume":"113","author":"Lerolle","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.nefro.2021.04.007_bib0310","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3928\/0090-4481-19871201-09","article-title":"Urolithiasis in children: the role of hypercalciuria","volume":"16","author":"Stapleton","year":"1987","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.nefro.2021.04.007_bib0315","first-page":"e86","article-title":"Kidney stones: a global picture of prevalence, incidence, and associated risk factors","volume":"12","author":"Romero","year":"2010","journal-title":"Rev Urol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0320","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(01)05782-8","article-title":"Recurrent renal stone disease-advances in pathogenesis and clinical management","volume":"358","author":"Bihl","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.nefro.2021.04.007_bib0325","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/003655901750170461","article-title":"Urinary tract infection in children associated with idiopathic hypercalciuria","volume":"35","author":"Vachvanichsanong","year":"2001","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0330","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00240-016-0933-2","article-title":"Are there any predictors of pyonephrosis in patients with renal calculus disease?","volume":"45","author":"Patodia","year":"2017","journal-title":"Urolithiasis"},{"key":"10.1016\/j.nefro.2021.04.007_bib0335","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1523-1755.2003.00763.x","article-title":"Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis","volume":"63","author":"Asplin","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2021.04.007_bib0340","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/ndt\/17.8.1396","article-title":"Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers","volume":"17","author":"Freundlich","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2021.04.007_bib0345","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s004670050341","article-title":"Bone mineral density in pediatric patients with idiopathic hypercalciuria","volume":"11","author":"Garc\u00eda-Nieto","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0350","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.2215\/CJN.01420217","article-title":"Low bone density and bisphosphonate use and the risk of kidney stones","volume":"12","author":"Prochaska","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0355","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000365038","article-title":"Reduced bone mass in 7-year-old children with asymptomatic idiopathic hypercalciuria","volume":"64","author":"Escribano","year":"2014","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.nefro.2021.04.007_bib0360","first-page":"2083","article-title":"Longitudinal study, bone mineral density in children diagnosed with idiopathic hypercalciuria","volume":"24","author":"Garc\u00eda Nieto","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0365","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/end.1999.13.679","article-title":"Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis","volume":"13","author":"Pearle","year":"1999","journal-title":"J Endourol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0370","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.juro.2006.11.040","article-title":"Adverse metabolic side effects of thiazides: implications for patients with calcium nephrolithiasis","volume":"177","author":"Huen","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0375","doi-asserted-by":"crossref","first-page":"658","DOI":"10.7326\/0003-4819-130-8-199904200-00012","article-title":"Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide","volume":"130","author":"Adams","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefro.2021.04.007_bib0380","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s004670050398","article-title":"Sodium transport and bone mineral density in hypercalciuria with thiazide treatment","volume":"12","author":"Reusz","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0385","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00467-011-1952-4","article-title":"Longitudinal study of bone mineral density in children with idiopathic hypercalciuria","volume":"27","author":"Moreira Guimar\u00e3es Penido","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0390","first-page":"32","article-title":"Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison","volume":"7","author":"Spence","year":"2000","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0395","first-page":"363","article-title":"Citrate and renal stones","volume":"73","author":"del Valle","year":"2013","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.nefro.2021.04.007_bib0400","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0022-5347(17)35888-3","article-title":"Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis","volume":"150","author":"Barcelo","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0405","first-page":"1036","article-title":"Effect of potassium citrate in the prophylaxis of urinary lithiasis","volume":"54","author":"Jim\u00e9nez Verdejo","year":"2001","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0410","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1590\/S1677-55382011000500007","article-title":"Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy","volume":"37","author":"Lojanapiwat","year":"2011","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0415","article-title":"Citrate salts for preventing and treating calcium containing kidney stones in adults","volume":"10","author":"Phillips","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nefro.2021.04.007_bib0420","first-page":"113","article-title":"Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi","volume":"83","author":"Thomas","year":"1972","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.nefro.2021.04.007_bib0425","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-5347(17)55749-3","article-title":"Treatment of recurrent calcium stone formation with cellulose phosphate","volume":"123","author":"Backman","year":"1980","journal-title":"J Urol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0430","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(76)90170-4","article-title":"Recurrent nephrolithiasis: natural history and effect of phosphate therapy. A double-blind controlled study","volume":"61","author":"Ettinger","year":"1976","journal-title":"Am J Med"},{"key":"10.1016\/j.nefro.2021.04.007_bib0435","first-page":"1257","article-title":"Incidence of lithiasic recurrence after a diuretic therapy, alone or combined with treatment by a thiazide diuretic or phosphorus","volume":"13","author":"Ulmann","year":"1984","journal-title":"Presse Med"},{"key":"10.1016\/j.nefro.2021.04.007_bib0440","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1523-1755.1999.00247.x","article-title":"Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats","volume":"55","author":"Bushinsky","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2021.04.007_bib0445","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jbmr.5650100420","article-title":"Prevention of hypercalciuria and stone-forming propensity during prolonged bedrest by alendronate","volume":"10","author":"Ruml","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.nefro.2021.04.007_bib0450","first-page":"9","article-title":"Treatment with hydrochlorothiazide and alendronate in patients with stones and bone mineral density loss. Evolution of bone metabolism and calciuria with medical treatment","volume":"69","author":"Arrabal-Mart\u00edn","year":"2016","journal-title":"Arch Esp Urol"},{"issue":"Suppl. 1","key":"10.1016\/j.nefro.2021.04.007_bib0455","first-page":"S11","article-title":"The CARI guidelines, kidney stones: prevention of recurrent calcium nephrolithiasis","volume":"12","author":"Kairaitis","year":"2007","journal-title":"Nephrology"},{"key":"10.1016\/j.nefro.2021.04.007_bib0460","article-title":"Medical and dietary interventions for preventing recurrent urinary stones in children","volume":"11","author":"Kern","year":"2017","journal-title":"Cochrane database Syst Rev"},{"key":"10.1016\/j.nefro.2021.04.007_bib0465","article-title":"Pharmacological interventions for preventing complications in idiopathic hypercalciuria","volume":"1","author":"Escribano","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nefro.2021.04.007_bib0470","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004754","article-title":"Pharmacological interventions for preventing complications in idiopathic hypercalciuria","volume":"2","author":"Escribano","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nefro.2021.04.007_bib0475","series-title":"Cochrane handbook for systematic reviews of interventions","year":"2019"},{"key":"10.1016\/j.nefro.2021.04.007_bib0480","series-title":"GRADEpro GDT: GRADEpro guideline development tool [computer program]","year":"2015"},{"key":"10.1016\/j.nefro.2021.04.007_bib0485","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.nefro.2021.04.007_bib0490","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfn690","article-title":"Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments","volume":"24","author":"Giusti","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2021.04.007_bib0495","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/00365598709180789","article-title":"Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stones","volume":"21","author":"Ala-Opas","year":"1987","journal-title":"Scand J Urol Nephrol"},{"issue":"Suppl. 6","key":"10.1016\/j.nefro.2021.04.007_bib0500","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/00005344-199312050-00014","article-title":"Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences","volume":"22","author":"Borghi","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0505","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0210-4806(06)73444-1","article-title":"Papel de las tiazidas en la profilaxis de la litiasis c\u00e1lcica recidivante","volume":"30","author":"Fern\u00e1ndez-Rodr\u00edguez","year":"2006","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.nefro.2021.04.007_bib0510","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1464-410X.1992.tb15624.x","article-title":"Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria","volume":"69","author":"Ohkawa","year":"1992","journal-title":"Br J Urol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0515","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0022-5347(01)62749-6","article-title":"Physiological effects of slow release potassium phosphate for absorptive hypercalciuria: a randomized double-blind trial","volume":"160","author":"Breslau","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0520","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000045089","article-title":"Effect of etidronate treatment on bone mass of male nephrolithiasis patients with idiopathic hypercalciuria and osteopenia","volume":"79","author":"Heilberg","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.nefro.2021.04.007_bib0525","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1210\/jc.2011-3492","article-title":"Clinical review, Kidney stones 2012: pathogenesis, diagnosis, and management","volume":"97","author":"Sakhaee","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nefro.2021.04.007_bib0530","doi-asserted-by":"crossref","first-page":"659","DOI":"10.7326\/M13-2908","article-title":"Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians","volume":"161","author":"Qaseem","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefro.2021.04.007_bib0535","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.eururo.2014.10.029","article-title":"Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines","volume":"67","author":"Skolarikos","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.nefro.2021.04.007_bib0540","article-title":"Dietary interventions for preventing complications in idiopathic hypercalciuria","volume":"2","author":"Escribano","year":"2014","journal-title":"Cochrane database Syst Rev"},{"key":"10.1016\/j.nefro.2021.04.007_bib0545","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1517\/14740338.2015.1100604","article-title":"Risks associated with drug treatments for kidney stones","volume":"14","author":"York","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.nefro.2021.04.007_bib0550","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ki.2010.389","article-title":"Pharmacotherapy of urolithiasis: evidence from clinical trials","volume":"79","author":"Moe","year":"2011","journal-title":"Kidney Int"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699521001508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699521001508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T20:02:45Z","timestamp":1731096165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699521001508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0211699521001508"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2021.04.007","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological interventions for preventing complications in patients with idiopathic hypercalciuria: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2021.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}